Working… Menu
Trial record 1 of 1 for:    NCT00962767
Previous Study | Return to List | Next Study

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00962767
Recruitment Status : Completed
First Posted : August 20, 2009
Last Update Posted : August 20, 2009
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007